Upadacitinib most effective oral JAK inhibitor for treating atopic dermatitis, study claims - Medical Dialogues
6/6/2022 12:00:00 AM2 years 11 months ago
by Medha Baranwal
by Medha Baranwal
USA: Janus kinase (JAK) inhibitors are an effective treatment for atopic dermatitis (AD) patients,...
USA: Janus kinase (JAK) inhibitors are an effective treatment for atopic dermatitis (AD) patients, according to results from a new systematic review. Upadacitinib, at 30 mg was shown to be the most e… [+2477 chars]
full article...